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Pharmacy 552 & 595 B.S. : Therapeutics III ( + ) Fall 2000
Lectures: M-W-Th-F 0910-1000 Rm 111, Skaggs Building
(note: Fri-Mon joint lectures with Pharm.D class in SB114) 
(note: 595 lectures on Thurs 1010-1100 in SB 336)
Course Coordinator: 
Instructors:
Michael Rivey = = > M. Rivey
Douglas Aliington Office: 243-6796 
Rose Macklin Community Hosp: 728-4100 
Cathy Bartels ext. 7605
Sarah Miller Pager: 329-6122
Gayle Cochran Home: 251-3369
Donna Beall Larry Dent 
Lee Ann Bradley Vince Colucci
William Docktor
Material and Resources 
Required Texts: DiPiro Pharmacotherapy, 4 th edition
Pray Nonprescription Product Therapeutics or APhA: Handbook
o f Nonprescription Drugs
Medical Letter on Drugs & Therapeutics
Goodman & Gilman's Pharmacological Basis o f Therapeutics
Boh Ciihicai Clerkship Manual
A medical dictionary
Optional Texts: Murphy: Clinical Pharmacokinetics pocket reference
Evans: Applied Pharmacokinetics
Young, Koda-Kimble: Applied Therapeutics
Herfindal, Gourley, Hart: Clinical Pharmacy and Therapeutics
Hansten & Horn: Drug Interactions
Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text
Goals of the Course
To promote the students' understanding of common disease 
states w ith particular emphasis on the facets o f diseases 
that are amenable to drug therapy.
To familiarize the student w ith the proper use of drugs in 
a clinical setting.
To develop the students' awareness of factors that should be 
considered prior to selection of a drug and the appropriate 
parameters that should be monitored for therapeutic as well 
as undesired effects.
To encourage the students' ability to problem-solve in the 
clinical setting.
GRADING IN COURSE: Phar 552-BS Therapeutics
3 midterm exams: 100 points each 3 0 0  points 
Final exam (comprehensive, multiple choice)
(100 pts comprehensive, 30  pts over last 6 lectures)
130  points
Topic quizzes: 8 quizzes graded on 10 pts each Bonus pts >  75%
TOTAL POINTS FOR COURSE 4 3 0  POINTS
Class quizzes: The purposes of the quizzes are to promote reading of the text before a 
topic and encourage class attendance and attention. Quizzes will occur after topic lectures 
and will test understanding of basic concepts in the reading assignments as well as issues 
discussed or emphasized in lecture. A quiz will consist of 5 multiple choice or true/false 
questions, each worth 2 points. Quiz on syllabus indicates a quiz will be given for the 
overall topic at end of the given lecture. Lowest 2 quiz grades will be thrown out; no 
make-ups will be allowed for quiz. Scoring: Quiz performance can only benefit student; 
bonus points for the course will be awarded for all points over 7 5%  (i.e. 60 pts) of the 
potential total 80  pts on the quizzes (10 total quizzes -  2 throw-outs = 8x10 pts)
NOTE: Reading assignments are from DiPiro (4th edition) & Pray books
Integrated Studies Conferences: you will be assigned to a conference based on period you 
registered for; instructors are not necessarily the ones under which you registered. 
Attendance/make-up is required for all topics/cases; you may attend a different conference 
in order to complete the assignment, with instructor permission. The "make-up" 
requirement for a conference will be at the discretion of the instructor, dependent on the 
topic.
Exams:
3 midterm exams: Tests will be in "traditional" case report fashion with short answers 
required. Tests will be given during a "common" time period of 8 -1 0A M  on select 
Thursdays. B.S. and Pharm.D. classes will take tests simultaneously.
Final exam: 65 multiple choice questions worth 2 pts each. Effort will be made to design 
questions in the style similar to the NAPLEX exam.
Class civility: Your student colleagues have strongly indicated to us that they wish to 
spend their valuable time in class listening to therapeutics topics. They do not appreciate 
any "side" conversations while the instructor is lecturing. They do appreciate students 
raising questions about important lecture aspects for further discussion or clarification.
Out of respect for your classmates, we will not tolerate excessive and disruptive 
talking during lecture. The instructor may first ask you to be silent; you may be asked to 
leave class if you persist in disruptive talking. The instructor will be the judge of "what" 
constitutes disruption. Please note that we encourage questions and relevant discussion.
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Performance Objectives
Upon completion of this course, each student shall be able to:
Relate the pathophysiology of a disease to the known or purported action of a drug.
Evaluate the seriousness of a disorder based on the signs and symptoms related to a 
diagnosed problem, and:
-determine the necessity of drug therapy,
-w hen applicable, choose the proper drug and/or 
drug product for the situation.
Determine the place of non-pharmacologic and natural therapies, when applicable.
Tailor the drug therapy of an individual based on patient characteristics and known 
pharmacokinetics principles.
Identify potential drug-drug interactions.
Monitor the appropriate parameters of a disease to determine if the patient is 
responding positively to the'fapy.
Monitor for adverse drug reactions and exacerbations of underlying patient problems 
resulting from drug therapy.
Student Responsibilities and Obligations
* To attend and participate in lecture sessions.
* To do assigned readings from the texts.
* To attend Integrated Studies conferences, prepare each case in advance, prepare 
to present a patient case, and participate in the discussion of all patient 
presentations.
* To perform satisfactorily on course quizzes and lecture examinations.
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GRADING IN COURSE: Phar 552-BS Therapeutics
3 midterm exams: 100 points each 300 points 
Final exam {comprehensive, multiple choice) 130 points
(100 pts comprehensive, 30 pts over last 6 lectures)
Topic quizzes: 8 quizzes graded on 10 pts each Bonus pts > 75%
TOTAL POINTS FOR COURSE 430 POINTS
Class quizzes: The purposes of the quizzes are to promote reading of the text before a 
topic and encourage class attendance and attention. Quizzes w ill occur after topic lectures 
and will test understanding of basic concepts in the reading assignments as well as issues 
discussed or emphasized in lecture. A quiz will consist of 5 multiple choice or true/false 
questions, each worth 2 points. Quiz on syllabus indicates a quiz will be given for the 
overall topic at end of the given lecture. Lowest 2 quiz grades will be thrown out; no 
make-ups will be allowed for quiz. Scoring: Quiz performance can only benefit student; 
bonus points for the course will be awarded for all points over 75% (i.e. 60 pts) of the 
potential total 80 pts on the quizzes {10 total quizzes -  2 throw-outs = 8x10 pts)
NOTE: Reading assignments are from DiPiro (4th edition) & Pray books
Integrated Studies Conferences: you w ill be assigned to a conference based on period you 
registered for; instructors are not necessarily the ones under which you registered. 
Attendance/make-up is required for all topics/cases; you may attend a different conference 
in order to complete the assignment, w ith instructor permission. The "make-up" 
requirement for a conference will be at the discretion of the instructor, dependent on the 
topic.
Exams:
3 midterm exams: Tests will be in "traditional" case report fashion w ith short answers 
required. Tests will be given during a "common" time period of 8-10AM on select 
Thursdays. B.S. and Pharm.D. classes will take tests simultaneously.
Final exam: 65 multiple choice questions worth 2 pts each. Effort will be made to design 
questions in the style similar to the NAPLEX exam.
Class civility: Your student colleagues have strongly indicated to us that they wish to 
spend their valuable time in class listening to therapeutics topics. They do not appreciate 
any "side" conversations while the instructor is lecturing. They do appreciate students 
raising questions about important lecture aspects for further discussion or clarification.
Out of respect for your classmates, we will not tolerate excessive and disruptive 
talking during lecture. The instructor may first ask you to be silent; you may be asked to 
leave class if you persist in disruptive talking. The instructor w ill be the judge of "what" 
constitutes disruption. Please note that we encourage questions and relevant discussion.
Therapeutics III 552 B.S. & Phar 595 supplemental course; Lecture Syllabus
Instructor Reading (DiPiro, Pray)
6W Introduction/ Liver disease MPR
7Th Liver disease MPR 35, 38
7Th Liver disease (10AM in SB 114) MPR (595)
8F Renal disease (10AM in SB 114) DRA 40
11M Renal disease/ quiz DRA 42
13W Hypertension LAD JNC-6
14Th HTN LAD 10
14Th HTN LAD (595)
15F Pain Management (10 AM SB114) LAB 56, OTC 18
18M Pain mgmt (10AM SB114)/ quiz LAB
20W Hyperlipidemia LAD 19
21Th Hyperlipidemia LAD
21Th Drug Literature Evaluation CLB (595)
22F Headache (10AM SB 114) DB 57
25M Headache (10AM SB 414) DB OTC 18
27W Congestive Heart Failure VJC 11
28Th CHF/ quiz (10-11AM) VJC
28Th Drug Literature Evaluation (9-10AM) CLB (595)
29F Digoxin kinetics VJC
Oct 2M Dig. PK VJC
4W OFF DAY; CAREER FAIR
5 Th Test 1 at 8-10AM in SB 114; through Digoxin PK
5Th Drug Literature Evaluation CLB (595)
6F Coronary artery disease VJC 12
9M CAD VJC
11W Dysrhythmias VJC 14
12Th Arthritis MPR 83,84
12Th Arthritis MPR (595)
13F Arthritis/ quiz MPR OTC 18,20
16M Contraception DB OTC 43
18W Contraception/ quiz DB 76
19Th Diabetes meliitis LRM 70
19Th Contraception/ quiz DB (595)
20F DM LRM
552-Ther III & Phar 595, continued
Oct 23M DM/ quiz
25W Menopause
LRM
GAC
OTC 46 
78
26Th Menopause GAC
26Th Drug Literature Evaluation CLB (595)
27F Osteoporosis (10AM in SB 114) GAC 82, OTC pp.711,71; 
30M Osteoporosis (10AM in SB 114) GAC
Nov 1W Dementia GAC 61
2Th
2Th
3F
Test 2 at 8-10AM in SB 114; 
Drug Literature Evaluation
Fluid & electrolytes
through osteoporosis
CLB (595)
SJM DiPiro pp, 890-901 
6M Fluid & electrolytes SJM pp. 902-16 
8W Nutrition SJM
9Th Oncology overview CLB DiPiro pp.2013-41
9Th Drug Literature Evaluation CLB (595)
10F VETERANS DAY HOLIDAY
13M Oncology CLB
15W Nausea & vomiting . LAB 33, OTC 5
16Th Seizure disorders DRA 52
16Th Seizure dx/quiz DRA (595)
17F Anticonvulsant kinetics DRA
20M Thromboembolic dx (10AM in SB114)MPR 17
22W OFF; TRAVEL DAY
23Th THANKSGIVING HOLIDAY
24F
27M TED (10AM in SB 114)/ quiz MPR
29W Stroke MPR 18
30Th Thyroid disorders MPR 71
30Th Biostatistics overview TPS (595)
Dec 1F Obstructive Airways Disease (10AM in SB 114)
DRA 24, OTC 17
4M OAD (10 AM in SB 114) / quiz DRA 25
6W Theophylline kinetics DRA
7Th test 3 at 8 -10AM in SB 114; through OAD
7Th Biostatistics overview TPS (595)
8F Anxiety/sleep disorders WJD 67,69, OTC 24
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552-Ther III & Phar 595, continued
11M Attention deficit disorder WJD DiPiro pp. 1046-49
1 3W CLASS EVALUATION/ gout MPR 85
14Th Depression WJD 65
14Th Biostatistics overview TPS (595)
1 5F Depression/ quiz WJD
Phar 552-BS Final: test 4, 130 pts comprehensive multiple choice NAPLEX/PSAP format
NOTE: class w ill meet at 10AM on certain Mondays and Fridays throughout the semester
v
Pharmacy 595: supplemental course
Phar 595: Course is 1-hour Thursday session to supplement Ther-lll and cover other topics 
not in B.S. curriculum in an overview fashion. It is graded course
Schedule: merged to above syllabus (weekly on Thurs at 1010-1100 in SB 336)
Instructors: various Therapeutics instructors 
Cathy Bartels 
Tim Stratton
Grading in Phar 595:
6/14 of course grade: project in Drug Literature Evaluation
3/14 of course grade: biostatistics questions on Final Exam (add-on questions)
5/14 of course grade: grade obtained in Ther. Phar 552 course
integrated Studies Phar 574
I. Conference topics
Group 1: 
Group 2: 
SB 337 
SB 215 
Tues 0910-1100 
" " 
Colucci
Rivey
week of:
September 4M no conference
11M Liver disease case
18M Hypertension case
25M Headache/pain management
October 2M Digoxin kinetics
9M service learning update: J-club for Vz of class
16M OTC cases
23M Contraception
30M Diabetes
November 6M service learning update: J-club for other Vz of class
13M SEMINARS
20M o ff week- holiday week
27M TED case
December 4M OAD case
11M OTC cases
Seminar: A required activity in the course, graded on a pass/no-pass basis. Student must 
repeat a no-pass seminar to successfully pass course.
